Mayur is finishing his Ph.D in Biomedical Engineering at Columbia University where he cofounded Ardent Cell Technologies, a cell therapeutics company entering clinical trials. Before joining Columbia he worked at Boston Consulting Group designing predictive models and precision medicine product pipelines for healthcare giants like Boston Scientific. He believes that opportunities shaping and contributing towards value based care are the way forward.